SEARCH RESULTS FOR:

tosk
United States
Pharma & Life Sciences

Brian Frenzel

PRESIDENT & CEO, TOSK
United States Pharmaceuticals & Biopharmaceuticals 2021 - Digital Interactive
Tosk explains how it is successfully developing drugs to counter the side effects of cancer therapies.
United States
Pharma & Life Sciences

Brian Frenzel

CEO, TOSK
Tosk is developing a family of small molecule drugs to prevent the toxic side ef-fects of cancer treatments.
United States
Pharma & Life Sciences

Brian Frenzel

PRESIDENT AND CEO, TOSK, INC.
United States Biopharmaceuticals 2018
Tosk, Inc. is a small molecule, oncology drug discovery and development company.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL